Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3610 | Sham cTBS to the vmPFC Wiki | 1.00 |
| drug3611 | Sham iTBS to the dlPFC Wiki | 1.00 |
| drug3280 | Real cTBS to the vmPFC Wiki | 1.00 |
Navigate: Correlations HPO
There is one clinical trial.
The FDA has approved the CipherOx CRI T1 Tablet for use in subjects aged 19-36, and that this study aims to evaluate the device in subjects aged outside of this range and is being used off label. The FDA determined the Cipher OX CRI T1 Tablet to be a class II device in 2016, and additional research has been done since the FDA determination to further support the use of the device outside of its current labeling.
Description: Volume of IV fluid infused during treatment
Measure: Volume of IV fluid infused Time: 1 yearDescription: Amount of blood pressure medication utilized during treatment
Measure: Quantity of Blood pressure medication administered Time: 1 yearDescription: Categorical determination of resuscitation status as over- or under- resuscitated
Measure: Resuscitation status Time: 1 yearDescription: FiO2 levels administered
Measure: FiO2 needs Time: 1 yearDescription: Days spent on oxygen
Measure: Days on Oxygen Time: 1 yearDescription: Number of participants with hospital acquired pneumonia
Measure: Number of participants with hospital acquired pneumonia Time: 1 yearDescription: Number of patients who acquire an acute kidney injury
Measure: Number of Patients with Acute Kidney Injury (AKI) Time: 1 yearDescription: Number of patients who experience hemodynamic collapse defined as drop in systolic blood pressure below 80mm Hg
Measure: Number of patients with hemodynamic collapse Time: 1 yearDescription: Number of patients who experience mortality
Measure: mortality Time: 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports